editorials · reviews · multicenter studies · meta-analyses · randomized controlled trials · retractions
J Clin Psychiatry · May 2007
This study evaluated the efficacy and safety of desvenlafaxine succinate extended-release in major depressive disorder (MDD). ⋯ Desvenlafaxine is effective and well tolerated in the short-term treatment of MDD.
read on… or not…
We guarantee your privacy. Your email address will not be shared.
Receive a weekly email with the highest quality and most significant abstracts from critical care specialties.
Anesthesiology, Critical Care Medicine, Emergency Medicine, Medicine, and Pain medicine.
Includes a free 21 day trial of metajournal premium
We guarantee your privacy. Your email address will not be shared. Unsubscribe anytime.